Alzheimer's disease

Nasal Vaccine Starts Trial to Protect Against Alzheimer's
BioSpace
Tue, 11/16/21 - 10:31 pm
Alzheimer's disease
clinical trials
vaccines
I-Mab Biopharma
Jiangsu Nhwa Pharmaceutical
Anticipating Aduhelm's costs, Medicare plans big jump in premiums
BioPharma Dive
Mon, 11/15/21 - 12:42 pm
Medicare
Biogen
Aduhelm
Alzheimer's disease
Biogen Says Aduhelm Significantly Lowers Another Top Alzheimer's Biomarker
BioSpace
Sat, 11/13/21 - 09:53 pm
Biogen
Aduhelm
Alzheimer's disease
Cortexyme plans path forward for Alzheimer's drug that failed study
BioPharma Dive
Fri, 11/12/21 - 10:51 am
Cortexyme
Alzheimer's disease
clinical trials
Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy
Endpoints
Thu, 11/11/21 - 10:59 am
AC Immune
Roche
anti-tau antibodies
Alzheimer's disease
Eisai-Biogen Alzheimer's Drug Shows Amyloid Reduction, Disease-Modifying Effect
BioSpace
Thu, 11/11/21 - 10:55 am
Eisai
Biogen
lecanemab
Alzheimer's disease
clinical trials
Biogen's Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?
Fierce Pharma
Tue, 11/9/21 - 11:52 pm
Biogen
Aduhelm
patient deaths
Alzheimer's disease
Biogen to Present New Aduhelm Data at Upcoming Alzheimer’s Conference
BioSpace
Wed, 11/3/21 - 11:37 pm
Biogen
Aduhelm
Alzheimer's disease
CTAD
Augmented Reality Test Diagnoses and Tracks Alzheimer’s for Early Intervention
BioSpace
Wed, 11/3/21 - 10:49 am
Altoida
diagnostics
augmented reality
Alzheimer's disease
artificial intelligence
Cortexyme Loses 70% Of Its Value On Missed Alzheimer's Test — But There's A Caveat
Investors Business Daily
Tue, 10/26/21 - 11:45 pm
Cortexyme
Alzheimer's disease
clinical trials
atuzaginstat
Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm
Fierce Biotech
Tue, 10/26/21 - 10:50 am
Eli Lilly
Alzheimer's disease
FDA
donanemab
Biogen
Aduhelm
zagotenemab
Biogen's Alzheimer's drug is struggling, and a turnaround might not be coming soon
BioPharma Dive
Wed, 10/20/21 - 06:56 pm
Biogen
Aduhelm
Alzheimer's disease
Biogen CEO Says Alzheimer's Uptake 'Is Delayed,' But Shares Pop On Earnings Beat
Investors Business Daily
Wed, 10/20/21 - 10:32 am
Biogen
earnings
Aduhelm
Alzheimer's disease
Eisai-backed trial will assess Altoida’s digital test for early Alzheimer’s
Pharmaforum
Wed, 10/20/21 - 10:08 am
Altoida
Eisai
clinical trials
augmented reality
Alzheimer's disease
Alzheimer’s Drug Granted FDA Breakthrough Designation as Space Heats Up
BioSpace
Mon, 10/11/21 - 09:48 pm
Roche
FDA
breakthrough therapy
Alzheimer's disease
gantenerumab
Roche's Gantenerumab Gets FDA Breakthrough Therapy Designation for Alzheimer's Disease
Marketwatch
Sat, 10/9/21 - 10:58 pm
Roche
FDA
gantenerumab
Alzheimer's disease
breakthrough therapy
Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
Motley Fool
Fri, 10/8/21 - 10:43 am
Biogen
Aduhelm
Alzheimer's disease
Could Pfizer’s Inlyta have a role in Alzheimer’s disease?
Pharmaforum
Wed, 10/6/21 - 10:40 am
Pfizer
Inlyta
Alzheimer's disease
Mass General Brigham vetoes controversial Alzheimer's drug Aduhelm after internal review
Fierce Healthcare
Fri, 10/1/21 - 10:41 am
Massachusetts
hospitals
Biogen
Aduhelm
Alzheimer's disease
Despite rough start, Biogen's Aduhelm should find footing, analysts say. But don't expect much in 2021
Fierce Pharma
Wed, 09/29/21 - 11:58 pm
Biogen
Aduhelm
Alzheimer's disease

Pages